SOURCE: Wall Street Equity Research

Wall Street Equity Research

November 29, 2010 08:38 ET

Professional Research on Chembio Diagnostics Inc. and Biomoda Inc. -- Diagnostic Companies Benefiting From Government Grants

JOHANNESBURG, SOUTH AFRICA--(Marketwire - November 29, 2010) -  www.wallstreetequityresearch.com gives shareholders valuable insight on diagnostic substances stocks Chembio Diagnostics Inc. (OTCBB: CEMI) and Biomoda Inc. (OTCBB: BMOD). Sign up today at www.wallstreetequityresearch.com to receive free research reports on these equities.

Government grants and tax incentives from the Patent Protection and Affordable Care Act have recently helped out a number of smaller companies in the Healthcare Sector. Companies with, "Qualifying Therapeutic Discovery Projects," have been given grants to pursue advancements in diagnostic and therapeutic care, especially in the field of cancer and HIV. Visit us at http://www.wallstreetequityresearch.com/ to understand the catalysts and forces driving or affecting the diagnostic substances industry in today's economic environment.

www.wallstreetequityresearch.com is a specialized website where investors can have specific access to free reports diagnostic substances industry; traders looking for analyst opinions on Chembio Diagnostics Inc., Biomoda Inc. and other companies in this industry are welcomed to sign up for a free one year membership at http://www.wallstreetequityresearch.com/.

Two companies that have recently received government funding are Chembio Diagnostics Inc. and Biomoda Inc. Chembio recently announced government awards of over $1.4 million dollars relating to six of their ongoing projects. One such project is the development of rapid HIV diagnostic system. The company has posted positive quarterly financials, and is hoping to use the government funding to further their research. Traders can get direct and free access to today's full report on Chembio Diagnostics Inc. by signing up at http://wallstreetequityresearch.com/November292010ChembioDiagnosticsInc.(CEMI.OB)291110.php.

Biomoda has also picked up government funding for their research into the early detection of lung cancer. The company has created a compound that attaches itself to cancerous cells and gives off a red color under fluorescent light, making it easier detect the cells under a microscope. Traders can have complimentary access to today's complete research report on Biomoda Inc. by signing up at http://wallstreetequityresearch.com/November292010BiomodaInc.(BMOD.OB)291110.php

About Wall Street Equity Research: 

Wall Street Equity Research looks to bring simplicity and highly sophisticated research to an ever-changing investing environment. Wall Street Equity Research has been partnering with a number of North American and Emerging Economies analysts to bring you the best of both continents in terms of market analysis and analytical opinions. 

Contact Information